Levamlodipine Besylate Tablets 2.5 mg are a long-acting calcium channel blocker from Innovent Biologics, packed 21 tablets per box for hypertension and coronary care. GIVE LIFE TIME International supports distributors by assembling the regulatory file needed for cross-border pharmaceutical import. As a chronic-care essential, the product offers predictable, recurring demand that simplifies forecast and replenishment planning. Distributors value the stable prescription base because it supports longer-term supply agreements. Smoother warehouse planning compared with seasonal items makes it a dependable anchor SKU for tender portfolios.
The molecule relaxes vascular smooth muscle by limiting calcium entry through L-type channels, lowering peripheral resistance so blood pressure falls gradually. Once-daily dosing reflects its extended half-life, which helps maintain stable control across a 24-hour cycle. Compared with shorter-acting agents, the smooth profile reduces the trough-related pressure swings that concern prescribers.
The 2.5 mg strength serves essential hypertension and angina-related coronary disease management. It is a staple chronic-care product with steady, predictable demand in both public and retail channels. Combination with other antihypertensives is common in stepped-care protocols, widening its placement across formularies.
One tablet is taken orally once daily, with dose adjustment guided by the treating physician. The 21-tablet pack aligns with a three-week supply, a convenient unit for recurring prescription refills and tender forecasting. Procurement teams should note that blister format and printing language may differ by destination market. Stable content uniformity across batches simplifies pharmacy dispensing and reduces complaint risk. Buyers running multiple markets should confirm the approved artwork per destination before launch.
Protect from moisture at temperatures not exceeding 30°C. Compliance buyers must secure the NMPA registration number, GMP certificate, and stability data. GIVE LIFE TIME International bundles the manufacturer dossier with each export so registration authorities receive a complete submission, reducing the back-and-forth that delays market entry.
Q: Is this the same class as amlodipine? A: Yes, it is a third-generation dihydropyridine calcium antagonist with a similar channel mechanism and once-daily profile.
Q: What is the key export document? A: The NMPA registration certificate plus GMP proof forms the backbone of most import dossiers.
Q: How should shelf life be managed in hot climates? A: Keep cartons sealed and below 30°C; avoid prolonged warehouse heat that shortens remaining validity.
Q: Can the 21-tablet pack be split for samples? A: Sample releases should follow the manufacturer's labeling; splitting breaks the sealed unit and is not advised.
Levamlodipine Besylate Tablets 2.5 mg are a long-acting calcium channel blocker from Innovent Biologics, packed 21 tablets per box for hypertension and coronary care. GIVE LIFE TIME International supports distributors by assembling the regulatory file needed for cross-border pharmaceutical import. As a chronic-care essential, the product offers predictable, recurring demand that simplifies forecast and replenishment planning. Distributors value the stable prescription base because it supports longer-term supply agreements. Smoother warehouse planning compared with seasonal items makes it a dependable anchor SKU for tender portfolios.
The molecule relaxes vascular smooth muscle by limiting calcium entry through L-type channels, lowering peripheral resistance so blood pressure falls gradually. Once-daily dosing reflects its extended half-life, which helps maintain stable control across a 24-hour cycle. Compared with shorter-acting agents, the smooth profile reduces the trough-related pressure swings that concern prescribers.
The 2.5 mg strength serves essential hypertension and angina-related coronary disease management. It is a staple chronic-care product with steady, predictable demand in both public and retail channels. Combination with other antihypertensives is common in stepped-care protocols, widening its placement across formularies.
One tablet is taken orally once daily, with dose adjustment guided by the treating physician. The 21-tablet pack aligns with a three-week supply, a convenient unit for recurring prescription refills and tender forecasting. Procurement teams should note that blister format and printing language may differ by destination market. Stable content uniformity across batches simplifies pharmacy dispensing and reduces complaint risk. Buyers running multiple markets should confirm the approved artwork per destination before launch.
Protect from moisture at temperatures not exceeding 30°C. Compliance buyers must secure the NMPA registration number, GMP certificate, and stability data. GIVE LIFE TIME International bundles the manufacturer dossier with each export so registration authorities receive a complete submission, reducing the back-and-forth that delays market entry.
Q: Is this the same class as amlodipine? A: Yes, it is a third-generation dihydropyridine calcium antagonist with a similar channel mechanism and once-daily profile.
Q: What is the key export document? A: The NMPA registration certificate plus GMP proof forms the backbone of most import dossiers.
Q: How should shelf life be managed in hot climates? A: Keep cartons sealed and below 30°C; avoid prolonged warehouse heat that shortens remaining validity.
Q: Can the 21-tablet pack be split for samples? A: Sample releases should follow the manufacturer's labeling; splitting breaks the sealed unit and is not advised.
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
